Anticoagulant Citrate Phosphate Dextrose (Cpd) Solution And Adsol Preservation Solution Kit (Adsol Red Cell Preservation System In Plastic Container (Pl 146 Plastic))

Trade Name : ADSOL RED CELL PRESERVATION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC)

Fenwal, Inc.

KIT

Strength

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Anticoagulant Citrate Phosphate Dextrose (Cpd) Solution And Adsol Preservation Solution Kit (Adsol Red Cell Preservation System In Plastic Container (Pl 146 Plastic)) which is also known as ADSOL RED CELL PRESERVATION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) and Manufactured by Fenwal, Inc.. It is available in strength of per ml. Read more

Anticoagulant Citrate Phosphate Dextrose (Cpd) Solution And Adsol Preservation Solution Kit (Adsol Red Cell Preservation System In Plastic Container (Pl 146 Plastic)) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Click to know price. Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

About GNH

No data

Blood-Packu00a0Unit with an Integralu00a0Bioflex RC Leukocyte Reduction Filter Using CPD/Adsol Red Cell Preservation Solution for Whole Blood Collection and Filtration of Red Blood Cells
Contains Sample Diversion System for the collection of unanticoagulated whole blood samples for laboratory testing.
Integral filter unit intended for leukocyte reduction of AS-1 red blood cells:
The leukocyte reduced red blood cells may then be stored for the maximum allowable dating period.
Instructions for Use
Arrayn- Collection Procedure:
Use aseptic technique.
Notes:
Precautions:
1. Identify Blood-Pack Unit using appropriate donor identification system.
2. Adjust donor scale to desired collection weight and position primary container on the donor scale as far as possible below donor arm.
3. Clamp donor tubing between needle and Y-junction with a clamp. (This step may be performed prior to step 1 or 2.)
4. Visually inspect the tubing from the in-line cannula to the sample pouch and donor needle, as well as the sample pouch to reconfirm that there is no anticoagulant present.
Note: Ensure that the sample pouch remains below the donoru2019s arm
5. Following blood center procedures, apply pressure to donoru2019s arm and disinfect site of venipuncture.
6. Remove needle cover per instructions below:
a) Holding the hub and cover near the tamper-evident seal, twist cover and hub in opposite directions to break seal.
b) Remove needle cover, being careful not to drag the cover across the needle point.
7. Following blood center procedures, perform venipuncture, appropriately secure donor needle and/or tubing and release clamp on donor tubing. When good blood flow is established, stabilize the front of the needle guard to arm with tape (see Figure 2).
8. Allow the sample pouch to fill with blood according to center procedure. Monitor blood flow into sample pouch.
Notes:
Precautions:
9. Close the blue clamp on tubing between the Y-junction and the sample pouch.
10. Break the in-line cannula below the Y-junction in the donor tubing to the primary container allowing blood collection to proceed. To completely break the in-line cannula, grasp with both hands. Snap it at a 90u00b0 angle in one direction, and then bend it at a 90u00b0 angle in the opposite direction. Ensure the in-line cannula is completely broken and that the blood flows freely to the primary container.
Precaution: Failure to break the in-line cannula completely may result in restricted blood flow.
11. Mix blood and anticoagulant in the primary container immediately, at several intervals during collection, and immediately after collection.
12. Following blood center procedures, hermetically seal the tubing between the sampling site and the Y-junction to maintain sterility of the blood collection system prior to removing blood samples.
Warning:
13. To collect samples, insert the access device by pushing firmly into the sampling site until the membrane seal is penetrated.
Note: If the access device is assembled such that the outer barrel is screwed onto the Luer, make sure to rotate clockwise upon insertion to avoid barrel detaching from Luer.
14. Open the cap on the access device (if applicable). Hold access device so that the sample pouch hangs down.
15. Directly align the vacuum sample tube with the internal needle in the access device. Insert vacuum sample tube into device until the stopper is punctured.
16. Allow vacuum sample tube to fill with blood then remove from the access device.
17. Repeat steps 15 and 16 until the desired number of vacuum sample tubes have been filled.
Notes:
Precaution: When replacing access device, be careful to avoid contact with any blood droplets on the Luer or sampling site. Discard used access device appropriately.
18. Collect the appropriate volume based on Blood-Pack Unit used.
Note:
Precaution: Once the desired blood volume is collected, complete steps 19 u2013 23 within n- approximately 4 minutes to avoid possible clot formation in the tubing.
19. Release pressure on donoru2019s arm. If appropriate, apply clamp to donor tubing between needle and the Y-junction.
20. Hermetically seal donor tubing between the in-line cannula and the primary container.
21. (see Figure 3).
Precaution: The needle guard must be held stationary while the needle is withdrawn into it.
a) Place folded sterile gauze over puncture site and hold in place with finger tip without exerting pressure.
b) Hold sides of needle guard near the front, between the index finger and thumb. Pull the hub back smoothly until the needle is completely enclosed and securely locked into the needle guard.
c) Confirm the needle is completely enclosed and securely locked into the needle guard.
22. Remove and discard the sample diversion system and needle guard into an appropriate biohazardous waste container following established procedures. If donor tubing is also to be discarded, hermetically seal donor tubing directly above the primary container and remove.
Note:
23. If the donor tubing is not hermetically sealed directly above the primary container, then strip the blood from the remaining donor tubing into the primary container and mix. If desired, allow tubing to refill.
Arrayn- Component Preparation:
Notes:
a) Within 8 hours of blood collection if whole blood is held at ambient temperature.
b) Within 3 days of blood collection if whole blood is refrigerated.
24. At the appropriate time, prepare the Blood-Pack Unit with integral filter for centrifugation.
25. Thoroughly mix the primary container end over end.
26. Load the Blood-Pack Unit into a centrifuge cup per the instructions on page 3 or 4. Page 3 describes Option A, the method of centrifuge cup loading when using standard oval centrifuge cups. Page 4 describes Option B, the method of centrifuge cup loading when using large oval centrifuge cups. This method differs from Option A in steps 7 u2013 9 only and shows the use of a blood bag insert to help fill extra space inside the cup.n n -This guide is one method for centrifuge cup loading and applies to all Bioflex RC configurations. The specific stacking order and methods may vary depending on te workstation setup, centrifuge equipment, and your facilities Standard Operating Procedures. -It is important to pack the filter properly in the centrifugation cup to avoid damage to the filter during centrifugation. -Do not place the filter in the lower half of the centrifuge cup. See step 3 on page 3 or 4 for proper placement of filter. -Do not press directly on the cannulae while performing any of the cup loading steps as this may cause pre-activation of the cannulaen 27. After loading the Blood-Pack unit into the centrifuge cup, perform centrifugation according to center procedures.28.u00a0Following centrifugation, remove containers from the centrifuge cup taking care not to disturb the red blood cell / plasma interface.
29. Place primary container in a plasma extractor and apply pressure. Clamp off tubing above the filter to prevent plasma flow into filter during plasma transfer. If applicable, clamp off tubing below Y-Junction leading to secondary Transfer-Pack container not to be filled with plasma. Open the cannula on the top of the primary container to transfer plasma into the empty Transfer-Pack container.
30. When the desired amount of plasma has been removed, clamp the tubing between the plasma container and the Y-connector closest to the plasma container and release pressure on the primary container. Seal and remove satellite container(s).
31. Suspend the Adsol red cell preservation solution container ensuring that the primary container remains below the level of the filter during prime. Open the cannula on the Adsol solution container and remove the clamp between the primary container and the filter. Allow the Adsol to drain through the filter into the primary container. Clamp the tubing between the filter and the primary container after prime is complete.
32. Mix the Adsol red cell preservation solution and red cells thoroughly.
Note:
Arrayn- Filtration Procedure:
Precaution: Red blood cell products collected from certain donors may have extended n- filtration times and the potential for ineffective filtration and leukoreduction.
33. . Invert the unfiltered AS-1 red blood cells and hang the filter set such that the filter remains vertical. Filtration may be performed from 165 cm up to full length. To achieve maximum flow rate, allow the set to hang to full length. The storage container must remain below the level of the filter during filtration.
34. Filtration must be initiated up to 8 hours after collection at ambient condition or up to 3 days at refrigerated temperature.
35. Inspect all tubing to ensure it hangs freely without kinks.
36. Remove the clamp above the filter to start filtration.
Note: Manual or mechanical pressure should not be used to increase the flow rate through the filter. Tubing below the filter should not be stripped at any time during the filtration process.n n n n n n n
Note:
37. When filtration is complete, air can be observed in the inlet side of the filter. Hermetically seal and detach the tubing below the filter.
38. Make segments from the post filter tubing and leave segments attached to the filtered red cell storage container. (QC samples may be prepared by thoroughly mixing the filtered red cells and stripping this tubing prior to sealing the segments.)
39. Store the AS-1 red blood cells, leukocytes reduced between 1 and 6u00b0C.
40. Infuse the red cells within 42 days of collection.
41. Percent red blood cell recovery should be determined per FDA Guidance entitled u201cGuidance for Industry u2013 Pre-Storage Leukocyte Reduction of Whole Blood and Blood Components Intended for Transfusionu201d, current issue.n
Warning: Failure to achieve closed system processing conditions negates the extended storage claim and the red blood cell product must be transfused within 24 hours.n n n- Array
Data table below represents a summary of data generated under study protocol LERF-003-CMD. These data summarize Fenwal Bioflex RC filter performance under defined conditions of product usage.n n n n Store at Controlled Room Temperature. Protect from freezing. Avoid excessive heat.
Definition of u201cControlled Room Temperatureu201d:
u201cA temperature maintained thermostatically that encompasses the usual and customary working environment of 20u00b0 to 25u00b0C (68u00b0 to 77u00b0F); that results in a mean kinetic temperature calculated to be not more than 25u00b0C; and that allows for excursions between 15u00b0C and 30u00b0C (59u00b0 and 86u00b0F) that are experienced in pharmacies, hospitals, and warehouses. Provided the mean kinetic temperature remains in the allowed range, transient spikes up to 40u00b0C are permitted as long as they do not exceed 24 hours ... The mean kinetic temperature is a calculated value that may be used as an isothermal storage temperature that simulates the non isothermal effects of storage temperature variations.u201d
Reference: United States Pharmacopeia, General Notices. United States Pharmacopeial Convention, Inc. 12601 Twinbrook Parkway, Rockville, MD.n n n n n n n n n
u00a0n n n Fenwal, Inc.
Lake Zurich, IL 60047 USA
1-800-933-6925n
u00a92019 Fenwal, Inc. All rights reserved.
FENWAL, Blood-Pack, Transfer Pack, Adsol, and Bioflex RC are trademarks of Fenwal, Inc. Sorvall is a trademark og Thermo Fisher Scientific LLC. Beckman is trademark of Beckman Coulter, Inc.
07-19-13-427 REV: An

4R1790 9 Units Fenwaln Anticoagulant Citrate Phosphate Dextrose Solution, USP (CPD) BLOOD-PACK Unit; TRANSFER-PACK Container with ADSOL Red Cell Preservation Solution; Integral FENWAL BIOFLEX RC Red Cell Leukocyte Reduction Filter
Quadruple For the Collection and Processing of mL Blood
Sample Diversion System, 16 ga. Ultra Thin Wall Needle
Rx only
Each unit consists of a PL146 Plastic primary container with 70 mL of CPD solution containing u00a01.84 g Sodium Citrate (dihydrate) USP, 1.78 g Dextrose (monohydrate) USP, 209 mg Citric Acid (anhydrous) USP, 155 mg Monobasic Sodium Phosphate (monohydrate) USP, pH may have been adjusted with sodium hydroxide; three empty 400 mL PL2209 Plastic TRANSFER-PACK containers; one integral FENWAL BIOFLEX RC Red Cell Leukocyte reduction filter and one 450 mL PL2209 Plastic TRANSFER-PACK container with 110 mL of ADSOL Red Cell Preservation Solution containing 2.42 g Dextrose (monohydrate) USP, 990 mg Sodium Chloride USP, 825 mg Mannitol USP, 30 mg Adenine USP for the storage of AS-1 red blood cells, leukocytes reduced.
Sterile
See instructions for use.
I)u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0 Units are not removed from pouch, or
II)u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0 Unused units removed from pouch are returned to the pouch within 12 hours. Units may be removed from the pouch and returned only once.
FENWAL, BLOOD-PACK, ADSOL, BIOFLEX RC, and TRANSFER-PACK are trademarks of Fenwal, Inc.
Fenwal, Inc.
Lake Zurich, IL 60047 USA
Made in USA
07-28-10-994 REV: An n

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71245 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Get Price

Anticoagulant Citrate Phosphate Dextrose (Cpd) Solution And Adsol Preservation Solution Kit (Adsol Red Cell Preservation System In Plastic Container (Pl 146 Plastic))

Trade Name : ADSOL RED CELL PRESERVATION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC)

KIT

Delivery Process

Product information is meant for

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

Packaging and Delivery

About GNH

Similar Products

Desogestrel And Ethinyl Estradiol (Emoquette)

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Fluoxetine Hydrochloride (Fluoxetine)

Metoprolol Succinate (Metoprolol Succinate)

Losartan Potassium (Losartan Potassium)

Browse Our Services And Processes

Disclaimer

Browse from other international pharmaceuticals

General

US NDC

Canadian DIN

Swiss Drugs

NZ Drugs

FAQ

Can’t find what
you’re looking for?

COMPANY

SERVICES

QUICK LINKS

CONTACT US

Anticoagulant Citrate Phosphate Dextrose (Cpd) Solution And Adsol Preservation Solution Kit (Adsol Red Cell Preservation System In Plastic Container (Pl 146 Plastic))

Trade Name : ADSOL RED CELL PRESERVATION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC)

KIT

Delivery Process

Product information is meant for

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

Packaging and Delivery

About GNH

Similar Products

Desogestrel And Ethinyl Estradiol (Emoquette)

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Fluoxetine Hydrochloride (Fluoxetine)

Metoprolol Succinate (Metoprolol Succinate)

Losartan Potassium (Losartan Potassium)

Browse Our Services And Processes

Disclaimer

Browse from other international pharmaceuticals

General

US NDC

Canadian DIN

Swiss Drugs

NZ Drugs

FAQ

Can’t find what you’re looking for?

COMPANY

SERVICES

QUICK LINKS

CONTACT US

Can’t find what
you’re looking for?